Australia markets closed

PulteGroup, Inc. (PHM)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
53.45-0.05 (-0.09%)
At close: 4:03PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 514.14B
Enterprise value 314.95B
Trailing P/E 10.33
Forward P/E 17.83
PEG ratio (5-yr expected) 10.56
Price/sales (ttm)1.28
Price/book (mrq)2.17
Enterprise value/revenue 31.36
Enterprise value/EBITDA 78.12

Trading information

Stock price history

Beta (5Y monthly) 1.44
52-week change 3109.64%
S&P500 52-week change 343.49%
52-week high 354.71
52-week low 323.18
50-day moving average 349.72
200-day moving average 346.02

Share statistics

Avg vol (3-month) 33.08M
Avg vol (10-day) 32.54M
Shares outstanding 5264.48M
Implied shares outstanding 6N/A
Float 258.57M
% held by insiders 13.48%
% held by institutions 190.71%
Shares short (30 Mar 2021) 46.01M
Short ratio (30 Mar 2021) 41.94
Short % of float (30 Mar 2021) 42.56%
Short % of shares outstanding (30 Mar 2021) 42.27%
Shares short (prior month 25 Feb 2021) 45.49M

Dividends & splits

Forward annual dividend rate 40.56
Forward annual dividend yield 41.05%
Trailing annual dividend rate 30.48
Trailing annual dividend yield 30.90%
5-year average dividend yield 41.38
Payout ratio 49.65%
Dividend date 331 Mar 2021
Ex-dividend date 410 Mar 2021
Last split factor 22:1
Last split date 301 Sep 2005

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 12.75%
Operating margin (ttm)16.08%

Management effectiveness

Return on assets (ttm)9.68%
Return on equity (ttm)23.39%

Income statement

Revenue (ttm)11.04B
Revenue per share (ttm)41.10
Quarterly revenue growth (yoy)5.80%
Gross profit (ttm)2.79B
EBITDA 1.84B
Net income avi to common (ttm)1.39B
Diluted EPS (ttm)5.18
Quarterly earnings growth (yoy)30.50%

Balance sheet

Total cash (mrq)2.6B
Total cash per share (mrq)9.77
Total debt (mrq)3.34B
Total debt/equity (mrq)50.85
Current ratio (mrq)5.99
Book value per share (mrq)24.66

Cash flow statement

Operating cash flow (ttm)1.78B
Levered free cash flow (ttm)1.11B